Article Information
History
- February 22, 2022.
Article Versions
- You are currently viewing Version 1 of this article (February 22, 2022 - 00:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Rachel Sparks1,10,
- William W. Lau1,10,
- Can Liu1,2,
- Kyu Lee Han3,
- Kiera L. Vrindten1,
- Guangping Sun1,4,
- Milann Cox1,
- Sarah F. Andrews5,
- Neha Bansal1,
- Laura E. Failla1,
- Jody Manischewitz6,
- Gabrielle Grubbs6,
- Lisa R. King6,
- Galina Koroleva3,
- Stephanie Leimenstoll7,
- LaQuita Snow7,
- OP11 Clinical Staff8,
- Jinguo Chen3,
- Juanjie Tang6,
- Amrita Mukherjee3,
- Brian A. Sellers3,
- Richard Apps3,
- Adrian B. McDermott5,
- Andrew J. Martins1,
- Evan M. Bloch9,
- Hana Golding6,
- Surender Khurana6 and
- John S. Tsang1,3,*
- 1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
- 2Graduate Program in Biological Sciences, University of Maryland, College Park, MD, USA
- 3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
- 4Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA
- 5Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
- 6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
- 7Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA
- 8NIH Clinical Center, NIH, Bethesda, MD, USA
- 9Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- ↵*Correspondence: john.tsang{at}nih.gov
↵10 These authors contributed equally
Posted February 22, 2022.
Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19
